Metabolic associations with genes known to associate with bladder cancer (BLCAP), ovarian cancer (OCIAD1), and infertility caused by azoospermia (DAZAP1) could highlight the importance of integrating both methylation and metabolomics for assessing T2D complications. This evidence concerns the gene OCIAD1 and Azoospermia.